Experimental Hematology
Volume 38, Issue 1 , Pages 11-19 , January 2010

Quantification of transforming capacity and cooperation of defined genetic alterations in myeloid malignancies

  • Yildirim Dogan
    • ,
  • Arnold Ganser
    • ,
  • Michaela Scherr

      Affiliations

    • Drs. Scherr and Eder contributed equally to this work.
    • ,
  • Matthias Eder

      Affiliations

    • Corresponding Author InformationOffprint requests to: Matthias Eder, M.D., Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany
    • Drs. Scherr and Eder contributed equally to this work.

Received 2 July 2009 ,Revised 2 September 2009 ,Accepted 14 October 2009.

References 

  1. Gilliland DG. Hematologic malignancies. Curr Opin Hematol. 2001;8:189–119
  2. Jenkins BJ, Le F, Gonda TJ. A cell type-specific constitutive point mutant of the common beta-subunit of the human granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3, and IL-5 receptors requires the GM-CSF receptor alpha-subunit for activation. J Biol Chem. 1999;274:8669–8677
  3. Cammenga J, Horn S, Bergholz U, et al. Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate. Blood. 2005;106:3958–3961
  4. Alexander WS, Metcalf D, Dunn AR. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 1995;14:5569–5578
  5. Cotta CV, Tubbs RR. Mutations in myeloid neoplasms. Diagn Mol Pathol. 2008;17:191–199
  6. Hussein K, Bock O, Theophile K, et al. H. MPLW515L mutation in acute megakaryoblastic leukaemia. Leukemia. 2009;23:852–855
  7. Rosenbauer F, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet. 2004;36:624–630
  8. Pabst T, Mueller BU. Transcriptional dysregulation during myeloid transformation in AML. Oncogene. 2007;26:6829–6837
  9. Dirac AM, Bernards R. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J Biol Chem. 2003;278:11731–11734
  10. Nagel S, Scherr M, Kel A, et al. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3′-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res. 2007;67:1461–1471
  11. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498
  12. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296:550–553
  13. Scherr M, Battmer K, Ganser A, Eder M. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. Cell Cycle. 2003;2:251–257
  14. Schambach A, Wodrich H, Hildinger M, Bohne J, Kräusslick HG, Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther. 2000;2:435–445
  15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408
  16. Modlich U, Bohne J, Schmidt M, et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood. 2006;108:2545–2553
  17. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45
  18. Hildinger M, Abel KL, Ostertag W, Baum C. Design of 5′ untranslated sequences in retroviral vectors developed for medical use. J Virol. 1999;73:4083–4089
  19. Fröhling S, Scholl C, Gilliland DG, Levine RL. Genetics of myeloid malignancies- pathogenetic and clinical implications. J Clin Oncol. 2005;23:6285–6295
  20. Schlenk RF, Döhner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1909–1918
  21. Gery S, Gueller S, Nowak V, Sohn J, Hofmann WK, Koeffler HP. Expression of adaptor protein Lnk in leukemia cells. Exp Hematol. 2009;37:585–592
  22. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593–602

PII: S0301-472X(09)00397-X

doi: 10.1016/j.exphem.2009.10.006

Experimental Hematology
Volume 38, Issue 1 , Pages 11-19 , January 2010

Article Tools

* Image Usage & Resolution